2018
DOI: 10.1002/biot.201800488
|View full text |Cite
|
Sign up to set email alerts
|

Enhancing CHO by Systems Biotechnology

Abstract: Earlier this year in March we published the first part of this special issue series on "enhancing CHO by systems biotechnology" presenting 15 papers on this exciting topic to highlight the advances made in the field since the release of genome sequence information on CHO in 2011 [1] and on the Chinese Hamster in 2013. [2,3] With a new and much better assembled reference genome recently released, [4] we are on a good way to genome scale science for this important industrial cell line. In the current issue there… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 19 publications
(18 reference statements)
0
1
0
Order By: Relevance
“…In order to allow for a more direct comparison, we transiently expressed a model protein, hEPO-Fc, in several cell lines. We selected the common host cell lines CHO-K1 and CHO-S; dihydrofolate reductase deficient CHO-DUKX B11, as well as CHO-K1 0mM (a derivative of CHO-K1 adapted to growth in the absence of glutamine [19] ), and the subclones CHO-K1 1D9, CHO-K1 4F10, and CHO-S 4F11, all three selected from their respective host cell line for elevated transient protein production. [20] Batch cultures of all cell lines were either mock-transfected or transfected with 10 or 20 μg of plasmid DNA coding for hEPO-Fc under control of a CMV-promoter.…”
Section: Comparison Of Global Protein Synthesis To Intracellular Prodmentioning
confidence: 99%
“…In order to allow for a more direct comparison, we transiently expressed a model protein, hEPO-Fc, in several cell lines. We selected the common host cell lines CHO-K1 and CHO-S; dihydrofolate reductase deficient CHO-DUKX B11, as well as CHO-K1 0mM (a derivative of CHO-K1 adapted to growth in the absence of glutamine [19] ), and the subclones CHO-K1 1D9, CHO-K1 4F10, and CHO-S 4F11, all three selected from their respective host cell line for elevated transient protein production. [20] Batch cultures of all cell lines were either mock-transfected or transfected with 10 or 20 μg of plasmid DNA coding for hEPO-Fc under control of a CMV-promoter.…”
Section: Comparison Of Global Protein Synthesis To Intracellular Prodmentioning
confidence: 99%